Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 52 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 219 | 9,586−3.4%/yr | −3.4%/yr | 2.80.8× | 7% | 10,100 in 2030+0.8%/yr |
| Lumbar fusion | 199 | 8,753−1%/yr | −1%/yr | 2.50.8× | 2% | 9,020 in 2030+0.5%/yr |
| Cervical fusion & disc arthroplasty | 77 | 3,603−4%/yr | −4%/yr | 1.00.7× | 0% | 4,270 in 2030+2.9%/yr |
| Kyphoplasty & vertebroplasty | 23 | 2,826−4.2%/yr | −4.2%/yr | 0.80.8× | 27% | 3,540 in 2030+3.8%/yr |
| SI joint fusion | 23 | 583+5.4%/yr | +5.4%/yr | 0.20.5× | 32% | 500 in 2030−2.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 1,332 | 456,139+1.4%/yr | +1.4%/yr | 129.72.0× | 57% | 501,600 in 2030+1.6%/yr |
| Skin substitutes & wound grafts | 313 | 86,283+22%/yr | +22%/yr | 15.61.7× | 83% | 134,700 in 2030+7.7%/yr |
| Bone graft & orthobiologics | 57 | 2,787−2.3%/yr | −2.3%/yr | 0.81.0× | 2% | 3,030 in 2030+1.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 375 | 24,956+2.5%/yr | +2.5%/yr | 7.10.6× | 86% | 32,700 in 2030+4.6%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 35 | 2,932+9.5%/yr | +9.5%/yr | 0.80.8× | 78% | 6,310 in 2030+14%/yr |
| Spinal cord & DRG stimulation | 48 | 1,564−4.8%/yr | −4.8%/yr | 0.40.6× | 89% | 1,890 in 2030+3.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 147 | 24,119−1.9%/yr | −1.9%/yr | 6.92.0× | 85% | 23,300 in 2030−0.6%/yr |
| Superficial venous ablation | 224 | 22,010−1.1%/yr | −1.1%/yr | 6.31.2× | 98% | 24,700 in 2030+2%/yr |
| Dialysis access | 204 | 20,282−7.2%/yr | −7.2%/yr | 6.31.7× | 68% | 20,800 in 2030+0.5%/yr |
| Thrombectomy, IVC filters & venous stents | 42 | 4,550+3.4%/yr | +3.4%/yr | 1.41.2× | 29% | 6,830 in 2030+7%/yr |
| Carotid revascularization | 46 | 2,550−2.4%/yr | −2.4%/yr | 0.70.9× | 0% | 2,560 in 2030+0.1%/yr |
| Aortic endografts (EVAR/TEVAR) | 6 | 979−4.9%/yr | −4.9%/yr | 0.30.8× | 0% | 1,400 in 2030+6.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 233 | 17,286−1.1%/yr | −1.1%/yr | 5.50.8× | 15% | 19,300 in 2030+1.8%/yr |
| Cholecystectomy & appendectomy | 221 | 11,459−2.6%/yr | −2.6%/yr | 3.50.9× | 2% | 12,600 in 2030+1.6%/yr |
| Colorectal resection | 16 | 4,592−1.4%/yr | −1.4%/yr | 1.41.0× | 0% | 5,470 in 2030+3%/yr |
| Antireflux & hiatal hernia surgery | 37 | 2,040+1.2%/yr | +1.2%/yr | 0.60.8× | 0% | 2,990 in 2030+6.6%/yr |
| Breast reconstruction | 12 | 1,522−3.4%/yr | −3.4%/yr | 0.51.2× | 0% | 2,040 in 2030+5%/yr |
| Bariatric surgery | 3 | 481−12%/yr | −12%/yr | 0.10.8× | 0% | 400 in 2030−3.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 202 | 14,148−8%/yr | −8%/yr | 4.20.8× | 48% | 14,100 in 2030−0.1%/yr |
| Kidney stone management | 210 | 10,020+0.3%/yr | +0.3%/yr | 3.00.7× | 17% | 11,600 in 2030+2.5%/yr |
| Hysterectomy, hysteroscopy & ablation | 85 | 6,904+1.6%/yr | +1.6%/yr | 2.30.9× | 25% | 7,960 in 2030+2.4%/yr |
| Incontinence, prolapse & sacral neuromodulation | 73 | 5,242+0.1%/yr | +0.1%/yr | 1.60.7× | 20% | 6,070 in 2030+2.5%/yr |
| Prostatectomy & nephrectomy | 71 | 3,581+0.9%/yr | +0.9%/yr | 1.21.0× | 0% | 4,490 in 2030+3.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 131 | 15,296−0.9%/yr | −0.9%/yr | 4.61.0× | 88% | 19,700 in 2030+4.3%/yr |
| Ear tubes & middle ear surgery | 3 | 633−0.6%/yr | −0.6%/yr | 0.20.8× | 58% | 510 in 2030−3.5%/yr |
| Cochlear implants | 14 | 436+11%/yr | +11%/yr | 0.10.6× | 28% | 770 in 2030+9.8%/yr |
| Sleep apnea & airway implants | 8 | 343+39%/yr | +39%/yr | 0.10.5× | 11% | 410 in 2030+3.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 337 | 21,034+1.6%/yr | +1.6%/yr | 6.71.1× | 42% | 26,600 in 2030+4%/yr |
| Tumor & fibroid embolization | 34 | 1,753+3.4%/yr | +3.4%/yr | 0.50.9× | 40% | 4,240 in 2030+16%/yr |
| Tumor ablation | 8 | 940−1.6%/yr | −1.6%/yr | 0.31.1× | 0% | 1,020 in 2030+1.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 513 | 68,597+18%/yr | +18%/yr | 20.11.0× | 91% | 127,400 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 239 | 12,086−4.4%/yr | −4.4%/yr | 3.70.9× | 4% | 12,400 in 2030+0.5%/yr |
| EP ablation | 165 | 11,552+8.2%/yr | +8.2%/yr | 2.90.9× | 0% | 21,900 in 2030+11%/yr |
| LAA occlusion & loop recorders | 227 | 10,060+12%/yr | +12%/yr | 2.60.9× | 33% | 20,000 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 390 | 17,678−4.1%/yr | −4.1%/yr | 4.30.9× | 0% | 19,700 in 2030+1.8%/yr |
| Structural heart (TAVR, TEER) | 238 | 5,995+3.6%/yr | +3.6%/yr | 1.51.0× | 0% | 8,310 in 2030+5.6%/yr |
| Mechanical circulatory support | 3 | 1,597−4.2%/yr | −4.2%/yr | 0.51.1× | 0% | 1,700 in 2030+1%/yr |
| PFO & septal closure | 5 | 312+5.6%/yr | +5.6%/yr | 0.10.8× | 0% | 200 in 2030−7.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 48 | 1,774+17%/yr | +17%/yr | 0.51.3× | 0% | 3,530 in 2030+12%/yr |
| Stroke thrombectomy | 46 | 1,384+6.8%/yr | +6.8%/yr | 0.41.1× | 0% | 1,290 in 2030−1.1%/yr |
| DBS & VNS | 18 | 1,061−2.2%/yr | −2.2%/yr | 0.30.9× | 0% | 1,120 in 2030+0.8%/yr |
| CSF shunts | 11 | 827+0.6%/yr | +0.6%/yr | 0.21.5× | 0% | 910 in 2030+1.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 945 | 147,381−0.7%/yr | −0.7%/yr | 43.20.8× | 82% | 160,000 in 2030+1.4%/yr |
| Vitreoretinal surgery | 94 | 7,488−1.9%/yr | −1.9%/yr | 2.30.7× | 59% | 8,080 in 2030+1.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 1,451 | 361,322+0.6%/yr | +0.6%/yr | 112.01.1× | 55% | 413,200 in 2030+2.3%/yr |
| ERCP & endoscopic ultrasound | 165 | 12,633+0.7%/yr | +0.7%/yr | 3.91.3× | 1% | 15,600 in 2030+3.6%/yr |
| Bronchoscopy & lung nodule | 119 | 8,499+11%/yr | +11%/yr | 2.61.1× | 2% | 16,800 in 2030+12%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.